Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Anat Cohen-Dayag, PhD$170.4M
Market Cap • 23/04/20241993
(há 31 anos)
2000
(24 years ago)
NASDAQ
Listagem
Holon
69
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
CGENSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.